MedTrace Logo

ECoG BMI for Motor and Speech Control

NCT03698149 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2026-05-05

No results posted yet for this study

Summary

Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.

Conditions

Interventions

DEVICE

PMT/Blackrock Combination Device

PMT Subdural Cortical Electrodes/Blackrock NeuroPort Array and NeuroPort System

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • Karunesh Ganguly

    lead OTHER

Principal Investigators

  • Karunesh Ganguly, MD, PhD · University of California, San Francisco

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-09
Primary Completion
2030-08-15
Completion
2030-08-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03698149 on ClinicalTrials.gov